RTW Investments’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $60.5M | Hold |
17,687,772
| – | – | 0.52% | 42 |
|
|
2026
Q1 | $63.3M | Hold |
17,687,772
| – | – | 0.63% | 39 |
|
|
2025
Q4 | $62.1M | Hold |
17,687,772
| – | – | 0.62% | 43 |
|
|
2025
Q3 | $57.7M | Hold |
17,687,772
| – | – | 0.71% | 36 |
|
|
2025
Q2 | $43.3M | Hold |
17,687,772
| – | – | 0.62% | 39 |
|
|
2025
Q1 | $118M | Hold |
17,687,772
| – | – | 1.8% | 18 |
|
|
2024
Q4 | $222M | Hold |
17,687,772
| – | – | 3.36% | 7 |
|
|
2024
Q3 | $327M | Hold |
17,687,772
| – | – | 4.73% | 6 |
|
|
2024
Q2 | $381M | Hold |
17,687,772
| – | – | 5.9% | 2 |
|
|
2024
Q1 | $477M | Hold |
17,687,772
| – | – | 7.03% | 1 |
|
|
2023
Q4 | $530M | Hold |
17,687,772
| – | – | 8.28% | 1 |
|
|
2023
Q3 | $362M | Hold |
17,687,772
| – | – | 7.65% | 1 |
|
|
2023
Q2 | $351M | Hold |
17,687,772
| – | – | 6.69% | 2 |
|
|
2023
Q1 | $303M | Hold |
17,687,772
| – | – | 6.31% | 4 |
|
|
2022
Q4 | $346M | Buy |
17,687,772
+1,884,970
| +12% | +$34.7M | 7.07% | 3 |
|
|
2022
Q3 | $252M | Hold |
15,802,802
| – | – | 5.81% | 3 |
|
|
2022
Q2 | $217M | Hold |
15,802,802
| – | – | 5.62% | 3 |
|
|
2022
Q1 | $251M | Hold |
15,802,802
| – | – | 5.19% | 2 |
|
|
2021
Q4 | $345M | Hold |
15,802,802
| – | – | 5.04% | 2 |
|
|
2021
Q3 | $470M | Buy |
15,802,802
+812,516
| +5% | +$29.6M | 7.08% | 1 |
|
|
2021
Q2 | $664M | Sell |
14,990,286
-725,000
| -5% | -$31.5M | 10.02% | 1 |
|
|
2021
Q1 | $697M | Sell |
15,715,286
-1,344,925
| -8% | -$73.8M | 10.89% | 1 |
|
|
2020
Q4 | $936M | Buy |
17,060,211
+247,720
| +1% | +$9.03M | 15.7% | 1 |
|
|
2020
Q3 | $384M | Hold |
16,812,491
| – | – | 9.25% | 1 |
|
|
2020
Q2 | $352M | Hold |
16,812,491
| – | – | 9.9% | 1 |
|
|
2020
Q1 | $235M | Hold |
16,812,491
| – | – | 10.1% | 1 |
|
|
2019
Q4 | $383M | Buy |
16,812,491
+225,000
| +1% | +$3.76M | 14.44% | 1 |
|
|
2019
Q3 | $193M | Hold |
16,587,491
| – | – | 11.45% | 1 |
|
|
2019
Q2 | $249M | Buy |
16,587,491
+550,005
| +3% | +$9.6M | 13.29% | 1 |
|
|
2019
Q1 | $280M | Hold |
16,037,486
| – | – | 19.13% | 1 |
|
|
2018
Q4 | $236M | Buy |
16,037,486
+1,067,742
| +7% | +$17.7M | 21.64% | 1 |
|
|
2018
Q3 | $369M | Hold |
14,969,744
| – | – | 22.07% | 1 |
|
|
2018
Q2 | $289M | Hold |
14,969,744
| – | – | 20.88% | 1 |
|
|
2018
Q1 | $258M | Buy |
+14,969,744
| New | +$244M | 24.57% | 1 |
|
Other funds holding RCKT
NM
MC
RTW Investments's RCKT Position: Q2 2026 in Review
RTW Investments held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 17,687,772 shares worth $60.5M. The position accounts for 0.52% of the portfolio, ranked #42.
RTW Investments first reported a position in RCKT in Q1 2018 and has held it in 34 quarters since. The position peaked at $936M in Q4 2020. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.
- RTW Investments held 17,687,772 shares of Rocket Pharmaceuticals worth $60.5M as of Q2 2026.
- RTW Investments left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
- Rocket Pharmaceuticals made up 0.52% of RTW Investments's portfolio in Q2 2026, its #42 holding.
- RTW Investments first reported a position in Rocket Pharmaceuticals in Q1 2018 and has held it in 34 quarters since.
- RTW Investments's Rocket Pharmaceuticals position peaked at $936M in Q4 2020.
- 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.
Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.